Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
SPRY
#2601
ARS Pharmaceuticals, Inc. Common Stock
8.140
0
USD
+1.75%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+1.75%
Aylık Değişim
-3.10%
6 aylık değişim
-11.62%
Yıllık Değişim
-11.62%
Önceki Kapanış
8.000
0
Open
8.140
0
Bid
Ask
Low
8.140
0
High
8.140
0
Hacim
64
Piyasalar
ABD Borsası
Sağlık Hizmetleri
SPRY
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
35.14 M
94.4 M
96.5 M
98.12 M
99.3 M
—
Valuation ratios
Enterprise value
—
584.84 M
467.51 M
984.35 M
1.21 B
5.11 B
Price to earnings ratio
—
-9.68
-9.79
131.88
-6.7
-133.34
Price to sales ratio
—
255.65
17.71 K
12.12
13.63
49.67
Price to cash flow ratio
—
-8.39
-8.96
79.73
-6.72
-104.24
Price to book ratio
—
1.23
2.3
4.21
10.05
14.61
Enterprise value to EBITDA ratio
—
—
-6.93
-338.96
-5.99
-82.31
Profitability ratios
Return on assets %
-0.27
-0.12
-0.23
0.02
-0.52
-0.51
Return on equity %
-0.29
-0.13
-0.24
0.03
-1.5
-1.09
Return on invested capital %
-490.45
-367.52
-7 803.52
-118.26
-2 307.86
—
Gross margin %
100
100
100
100
97.44
400
Operating margin %
-84.51 K
-2 698.78
-225.07 K
-3.46
-212.92
-1 080.53
EBITDA margin %
-83.67 K
—
-224.82 K
-3.26
-221.09
-1 083.36
Net margin %
-84.41 K
-2 635.41
-181.22 K
8.97
-203.25
-1 015.77
Liquidity ratios
Quick ratio
—
—
—
14.04
6.48
29.14
Current ratio
17.56
51.01
96.92
14.26
7.28
31.11
Inventory turnover
—
—
—
0
0.12
—
Asset turnover
0
0
0
0.31
0.25
0.25
Solvency ratios
Debt to assets ratio
0.02
0
—
—
0.29
—
Debt to equity ratio
0.02
0
—
—
0.84
—
Long term debt to total assets ratio
0
0
—
—
0.29
—
Long term debt to total equity ratio
0
0
—
—
0.84
—
Per share metrics
Operating cash flow per share
—
-1
-0.62
0.13
-1.73
-1.74
EBIT per share
—
-0.89
-0.71
-0.03
-1.84
-1.82
EBITDA per share
—
—
-0.71
-0.03
-1.89
-1.83
Total debt per share
—
0.01
—
—
0.98
—
Cash per share
—
6.87
2.4
3.07
2.49
10.66
Net current asset value per share
—
6.95
2.43
3.26
2.89
12.28
Tangible book value per share
—
6.83
2.42
2.44
1.01
6.44
Working capital per share
—
6.81
2.41
3.04
2.49
10.62
Book value per share
—
6.83
2.42
2.51
1.16
6.94
Haberler
Northland, ARS Pharmaceuticals hissesine alım tavsiyesi verdi
William Blair, FDA etiket güncellemesi sonrası ARS Pharma hissesinde Outperform görüşünü koruyor
ARS Pharmaceuticals: Neffy's Slow Launch, No Guidance For 2026 Keep Me On Sidelines (SPRY)
Leerink raises ARS Pharmaceuticals stock price target on sales expansion
ARS Pharmaceuticals 4Ç 2025 tahminlerini aştı, hisse yükseldi
Earnings call transcript: ARS Pharmaceuticals beats Q4 2025 forecasts, stock rises
ARS Pharmaceuticals, Inc. (SPRY) Q4 2025 Earnings Call Transcript
ARS Pharmaceuticals kazancı $0,01 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek
ARS Pharmaceuticals earnings beat by $0.01, revenue topped estimates
ARS Pharmaceuticals, Inc. (SPRY) Reports Q4 Loss, Beats Revenue Estimates
Canadian Natural to Report Q4 Earnings: What's in the Offing?
ARS Pharmaceuticals, Inc. (SPRY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?